ACER — Acer Therapeutics Share News
0.000.00%
Last trade - 00:00U.S. STOCKS ON THE MOVE-Traeger, Range Resources, U.S. banks
Acer Therapeutics falls as drug for hot flashes fails study
U.S. STOCKS ON THE MOVE-First Republic Bank, Acer Therapeutics, Baidu
Brief: Acer Therapeutics Announces Topline Results From ACER-801 Phase 2a Trial
Acer Therapeutics to pause trial of hot flashes drug (updated)
Acer Therapeutics falls as drug for hot flashes fails study
Acer Therapeutics' hot flashes drug fails mid-stage study goal
Brief: Acer Therapeutics Announces Presentation Of HCP Urea Cycle Disorder Treatment Preference Data
Acer Therapeutics Inc expected to post a loss of 37 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Ralph Lauren, Howmet, Insulet
Acer Therapeutics rises on full enrollment of menopausal symptoms drug trial
Brief: Acer Therapeutics Filed A Prospectus To Offer And Sale Of Shares Of Its Common Stock Of Up To $11 Million
U.S. STOCKS ON THE MOVE-Lamb Weston Foldings, Stitch Fix, Bellerophon Therapeutics
Acer starts drug trials for a type of prostate cancer, shares rise
Brief: Acer Therapeutics Announces Initiation Of Two Investigator-Sponsored Trials Of Acer-801 (Osanetant) In Men With Adenocarcinoma Of The Prostate
Brief: Acer Therapeutics Enters Into Extension Agreement With Mam Aardvark, Lenders
Brief: Acer Therapeutics Compliant With All Nasdaq Listing Criteria
U.S. STOCKS ON THE MOVE-Camber Energy, Teck Resources, Tapestry
U.S. STOCKS ON THE MOVE-ProFrac, NextDecade, Gemini Therapeutics